A Phase 2, Randomized, Open-label Study of Nivolumab or Nivolumab/BMS-986205 Alone or Combinedwith Intravesical BCG in Participants with BCG-Unresponsive, High-Risk,Non-Muscle Invasive BladderCancer

Project: Research project


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Medicine and Dentistry